A Helsinki University Hospital study found diabetes, glycemic control, or insulin therapy did not significantly affect anatomical or functional outcomes after epiretinal membrane surgery.

Diabetic macular edema remains an important cause of vision ... techniques. The Diabetic Retinopathy Clinical Research (DRCR) Network, which includes over 199 participating sites, is currently ...

and for the treatment of macular edema following central retinal vein occlusion. It is also indicated for non-proliferative diabetic retinopathy (NPDR), diabetic macular edema(DME) and Diabetic ...

marking a significant milestone in the development of a potential new treatment for diabetic macular edema (DME), diabetic retinopathy (DR), and wet age-related macular degeneration (wet AMD).

diabetic retinopathy, and wet AMD, benefiting patients unresponsive to current treatments. The phase 1 clinical trial is a multicenter, open-label, dose-escalation study to assess drug safety via ...

Diabetic macular edema can result in low vision or vision loss. Early treatment can help preserve vision longer. Diabetic macular edema (DME) is a complication of diabetes. Over time, high blood ...

EYE-103 is under clinical development by Eyebiotech and currently in Phase III for Diabetic Macular Edema. According to GlobalData, Phase III drugs for Diabetic Macular Edema have a 62% phase ...

[17] Recently, the code combination 362.53 (cystoid macular edema) plus 250.xx (diabetes mellitus) was found to have high sensitivity and specificity for DME in a regional study of 22 ...

A recent cohort study revealed low adoption of FDA-approved AI-based diabetic retinopathy detection, with less than 5% of diabetic patients receiving ophthalmic imaging. Researchers emphasize the need ...

FAZ area deteriorated in stable eyes with proliferative diabetic retinopathy and macular capillary nonperfusion. The foveal avascular zone, or FAZ, area deteriorated at 12 months in eyes with ...